News Sentiment

1801 sentiment intelligence

Innovent Biologics, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 54 Balanced news tone 14 relevant articles
Exchange HKG Hong Kong
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 89.70 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 14

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+2.2% over one week, +17.3% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Innovent Biologics (SEHK:1801) Is Up 9.1% After Striking US$1.10 Billion IBI355 Licensing Deal

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 2.2% Price confirming higher
Trend fit Trend inactive 17.3% over four weeks
Fair value 55.6% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 11
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 14
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
simplywall.st 3
BioWorld News 3
Market source 2
thebambooworks.com 2
Bloomberg.com 1
Caixin Global 1
Reuters 1
PR Newswire 1

Event Lens

What the news is about

Classified themes
Market update 7
Deals and strategy 6
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-14 of 14